Search

Dr Akila Danga 07020434

Haematology

  • Fee assured
Overview

Specialises in

  • General
  • Haemato-oncology

About me

Dr Akila Danga is a Consultant Haematologist at The Hillingdon Hospital NHS Foundation trust with specialist interest in Haemato-Oncology, Principal Investigator in the latest Clinical Trials and key in the running of the busy medical haematology day unit.

Having graduated from Imperial College London in 2008 with a Distinction in Clinical Practice and an intercalated Batchelor of Sciences with 1st Class Honours, she completed her postgraduated medical training in London and Specialist Haematology training on the Imperial College London programme achieving her FRCPath accreditation in 2018.

Dr Danga is an enthusiastic and caring consultant specialising in the treatment of lymphoma, multiple myeloma, leukaemia, myelodysplasia and myeloproliferative disorders. She also runs clinics in the management of anaemia, immune-mediated thrombocytopenia, iron overload and deficiency, transfusion, thrombosis and bleeding, providing excellent clinical care to patients with Haematological disorders.

Areas of interest

Haemato-Oncology including Myeloma, Lymphoma, Myelodysplasia, Myeloproliferative disorders, Leukaemia and chemotherapy; General Haematology including Blood abnormalities; Anaemia; Iron deficiency; Vitamin B12 deficiency; Immune mediated thrombocytopenia; Auto-immune haemolytic Anaemia; White cell abnormalities; Haemochromatosis; Haemostasis and thrombosis; Transfusion medicine; Pre and post-operative optimisation of anaemia; Sickle cell disease; Thalassaemia.

My qualifications & training
Consultant's practices
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.